myCancerRisk

During the myCancerRisk test, the entire patient's genetic material is sequenced using the whole exome sequencing method (WES). 40 genetic mutations are analyzed that contribute to a higher risk of developing hereditary breast, gynecological, prostate, colorectal, stomach, pancreatic, skin, and other types of cancer. The results report provides a comprehensive interpretation of the test results, prepared by a genetics specialist, describing the detected mutations and indicating their possible implications for the patient's health.

Recommendation for when to perform the test: recommended for individuals at risk of cancer or those wishing to take a preventive test.

Samples: blood, saliva.

Execution time after reaching the laboratory: 4 weeks.